ImportRefusal LogoImportRefusal

Laboratorios Quimica Son's, S.A. de C.V.

🚨 Critical Risk

FEI: 3012825182 • Heroica Puebla De Zaragoza, Puebla • MEXICO

FEI

FEI Number

3012825182

📍

Location

Heroica Puebla De Zaragoza, Puebla

🇲🇽

Country

MEXICO
🏢

Address

Avenida 23 Poniente No. 2302, Col. El Aguila, Puebla, Heroica Puebla De Zaragoza, Puebla, Mexico

Critical Risk

FDA Import Risk Assessment

75.0
LowModerateHighCritical

This firm has an extensive history of FDA import refusals with severe violations.

Statistics

70
Total Refusals
6
Unique Violations
12/12/2025
Latest Refusal
5/17/2007
Earliest Refusal

Score Breakdown

Violation Severity
81.8×40%
Refusal Volume
68.6×30%
Recency
89.8×20%
Frequency
37.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7569×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1189×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4723×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4821×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

Refusal History

DateProductViolationsDivision
12/12/2025
64GCL07ESTRADIOL (ESTROGEN)
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)
6/3/2025
62GDE42INDOMETHACIN (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/4/2025
60SBY07PRECIPITATED CALCIUM CARBONATE (ANTACID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/4/2025
54AEY02VITAMIN B1 (THIAMINE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/4/2025
61HBY11SULFATHIAZOLE
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/4/2025
60LBF01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/4/2025
64LBJ03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/27/2025
64LDY03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/27/2025
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/26/2025
62GDA42INDOMETHACIN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/4/2024
61FDL55CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/29/2024
62GDY99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/29/2024
62GDY42INDOMETHACIN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/10/2024
61LDY06DIPHENADIONE (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/15/2024
61WDJ04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/24/2023
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/28/2023
64LDJ03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/27/2023
64LDY03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2022
62GDA42INDOMETHACIN (ANTI-INFLAMMATORY)
472NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/5/2022
62GDA42INDOMETHACIN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/29/2022
60LBE01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/29/2022
56KCJ99MISCELLANEOUS ANTIBIOTICS, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/27/2022
61SCO99ANTI-ECZEMATIC N.E.C.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/27/2022
64LCO37HYDROCORTISONE (GLUCOCORTICOID)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/27/2022
61VAA01SIMETHICONE (ANTI-FLATULENT)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/26/2022
64LDO37HYDROCORTISONE (GLUCOCORTICOID)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/22/2022
54CBK13L-LYSINE (PROTEIN)
472NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/15/2022
60LCJ37NALBUPHINE HCL (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/23/2022
62GDE42INDOMETHACIN (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/13/2022
56BCA03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/13/2022
64LCA27FLUOCINOLONE ACETONIDE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/10/2022
60QCK07LIDOCAINE
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/10/2022
64LCO03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/6/2022
61HBJ99ANTI-BACTERIAL, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/2/2021
62GCY50NAPROXEN SODIUM (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/30/2021
64LDY03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/12/2021
60QCA56BENZOCAINE (ANESTHETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/27/2021
60QDC40LIDOCAINE HCL (ANESTHETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/13/2021
64LBH03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/16/2021
64LBY03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/8/2020
62GCA99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/10/2020
62GAC99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/26/2019
60LCA82PHENAZOPYRIDINE HCL (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2019
61FDL55CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2019
56GDJ99ANTIFUNGAL N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/19/2019
64LDY37HYDROCORTISONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/30/2019
61HDL02TICLATONE (ANTI-BACTERIAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/29/2019
61WDO04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/16/2018
62GDH42INDOMETHACIN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/12/2018
60TDA14NALOXONE HCL (ANTAGONIST)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/17/2017
65PCA03TAMSULOSIN HCL (REGULATOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/25/2017
64LDJ03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/18/2017
62VCO69ACYCLOVIR; HYDROCORTISONE (ANTI-VIRAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/24/2017
61HDA99ANTI-BACTERIAL, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/24/2017
61HCY99ANTI-BACTERIAL, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/5/2017
61GCA04NALIDIXIC ACID (ANTI-BACTERIAL) (NOT ANTIBIOTIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/4/2017
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/9/2016
56YCK99ANTIBIOTIC N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/26/2016
62KCA10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/7/2016
62GCY18DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/19/2016
61WDO99A-FUNGAL N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/17/2016
61TDA29SCOPOLAMINE (ANTI-EMETIC/NAUSEANT)
118NOT LISTED
472NO ENGLISH
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/30/2016
65QDE22METHOCARBAMOL (RELAXANT)
324NO ENGLISH
482NUTRIT LBL
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/17/2016
61WCA47KETOCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Florida District Office (FLA-DO)
3/16/2016
62GDA42INDOMETHACIN (ANTI-INFLAMMATORY)
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/29/2012
66VCO99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/24/2011
62GCE42INDOMETHACIN (ANTI-INFLAMMATORY)
75UNAPPROVED
New Orleans District Office (NOL-DO)
10/21/2008
61WIY04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
5/17/2007
56JCE99LINCOMYCIN N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
5/17/2007
62KCE10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
75UNAPPROVED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Laboratorios Quimica Son's, S.A. de C.V.'s FDA import refusal history?

Laboratorios Quimica Son's, S.A. de C.V. (FEI: 3012825182) has 70 FDA import refusal record(s) in our database, spanning from 5/17/2007 to 12/12/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratorios Quimica Son's, S.A. de C.V.'s FEI number is 3012825182.

What types of violations has Laboratorios Quimica Son's, S.A. de C.V. received?

Laboratorios Quimica Son's, S.A. de C.V. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laboratorios Quimica Son's, S.A. de C.V. come from?

All FDA import refusal data for Laboratorios Quimica Son's, S.A. de C.V. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.